150 related articles for article (PubMed ID: 22425657)
1. Response-adaptive designs for continuous treatment responses in phase III clinical trials: A review.
Biswas A; Bhattacharya R
Stat Methods Med Res; 2016 Feb; 25(1):81-100. PubMed ID: 22425657
[TBL] [Abstract][Full Text] [Related]
2. Bayesian optimal response-adaptive design for binary responses using stopping rule.
Komaki F; Biswas A
Stat Methods Med Res; 2018 Mar; 27(3):891-904. PubMed ID: 27142983
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine for the reduction of perinatal transmission of human immunodeficiency virus.
Yoder DK
J Tenn Med Assoc; 1995 Jul; 88(7):272, 274. PubMed ID: 7658693
[No Abstract] [Full Text] [Related]
4. Zidovudine and prevention of perinatal HIV transmission.
Legg JJ; Goldschmidt RH
Am Fam Physician; 1995 Sep; 52(3):745, 748-50. PubMed ID: 7653413
[No Abstract] [Full Text] [Related]
5. A class of Covariate-Adjusted Response-Adaptive Allocation Designs for Multitreatment Binary Response Trials.
Biswas A; Bhattacharya R
J Biopharm Stat; 2018; 28(5):809-823. PubMed ID: 29913107
[TBL] [Abstract][Full Text] [Related]
6. HIVNET 012 and Petra.
Jackson B; Mmiro F;
Lancet; 2004 Jan; 363(9404):245; author reply 245-6. PubMed ID: 14738808
[No Abstract] [Full Text] [Related]
7. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
Biswas A; Huang HH; Huang WT
J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
[TBL] [Abstract][Full Text] [Related]
8. Maternal-infant transmission of HIV infection: use of zidovudine.
Klaus BD
Nurse Pract; 1995 Apr; 20(4):70-2. PubMed ID: 7596533
[No Abstract] [Full Text] [Related]
9. No adverse effects in infants following short-course zidovudine.
AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877
[No Abstract] [Full Text] [Related]
10. Optimal response-adaptive designs for continuous responses in phase III trials.
Biswas A; Bhattachary R; Zhang L
Biom J; 2007 Dec; 49(6):928-40. PubMed ID: 17722195
[TBL] [Abstract][Full Text] [Related]
11. Tackling mother-to-child HIV in Côte d'Ivoire.
Feinmann J
Lancet; 1997 Oct; 350(9084):1084. PubMed ID: 10213564
[No Abstract] [Full Text] [Related]
12. AZT trial in Thailand.
Lallemant M; Le Coeur S; McIntosh K; Brennan T; Gelber R; Lee TH; Hammer S; Essex M; Vithayasai V; Sirivatanapa P
Science; 1995 Nov; 270(5238):899-900. PubMed ID: 7481781
[No Abstract] [Full Text] [Related]
13. Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Thea DM
N Engl J Med; 1995 Mar; 332(13):892. PubMed ID: 7870154
[No Abstract] [Full Text] [Related]
14. Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
De Roo A; Colebunders R
N Engl J Med; 1995 Mar; 332(13):892. PubMed ID: 7870153
[No Abstract] [Full Text] [Related]
15. Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Hoffman CA; Munson R
N Engl J Med; 1995 Mar; 332(13):891-2. PubMed ID: 7870152
[No Abstract] [Full Text] [Related]
16. ZDV reduces maternal transmission.
AIDS Patient Care; 1994 Jun; 8(3):164. PubMed ID: 11362140
[No Abstract] [Full Text] [Related]
17. [Vertical transmission of HIV treated with zidovudine in county hospitals in Catalonia].
Tapiz A; Dorca E; Force L; Aranda M
Med Clin (Barc); 1999 Sep; 113(9):357. PubMed ID: 10562932
[No Abstract] [Full Text] [Related]
18. [Prevention of mother-child HIV transmission: a shortened and simplified zidovudine treatment].
Sante; 2000; 10(6):406. PubMed ID: 11345936
[No Abstract] [Full Text] [Related]
19. Hospital variation in intrapartum use of zidovudine.
Gwinn M; Mei JV; Spruill CL; Dobbs TL; Hannon WH; LaLota M
JAMA; 1997 Jan 22-29; 277(4):299. PubMed ID: 9002490
[No Abstract] [Full Text] [Related]
20. Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress.
Biswas A
Stat Methods Med Res; 2001 Oct; 10(5):353-64. PubMed ID: 11697227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
